Over the last 30 years, and 10+ million cell cultures, the clinical benefits of LRA tests and treatment plans have been confirmed many times and in many patient types.
Learn how LRA has helped patients just like yours.
Effective December 18, 2024, ELISA/ACT Biotechnologies will be temporarily closing for operational research and improvement